Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

BridgeBio Pharma

Tracked across 3 events · 54 articles · First seen Jun 11, 2026 · Last active Sep 04, 2026

Sentiment
37
Attention
6
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: BridgeBio Pharma formed a strategic distribution partnership with DKSH to support regulatory evaluation and potential patient access to its transthyretin stabilizer for ATTR-CM in key Asia Pacific markets, leveraging DKSH's commercialization platform.
Jun 11, 2026 · 9 articles
2 0
Business
Impact: BridgeBio Pharma is the issuer of the shares being sold in the secondary offering. The company does not receive any proceeds, but the offering diversifies its shareholder base, which may be seen as a positive for long-term ownership stability.
Aug 13, 2026 · 8 articles
6 40
Domestic
On August 31, 2026, President Donald Trump announced voluntary drug pricing agreements with nine pharmaceutical companies: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio Pharma, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB. These companies agreed…
Impact: BridgeBio Pharma joined the MFN pricing agreement, offering drugs at reduced prices to United States — Medicaid. This may lower U.S. revenue but provides tariff relief and supports patient access.
Aug 18, 2026 · 37 articles
ERGEN INTELLIGENCE
Track BridgeBio Pharma live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.